Search for: "Novartis Pharma AG"
Results 81 - 100
of 124
Sort by Relevance
|
Sort by Date
28 Jul 2010, 12:06 am
(Patent Docs) Levitra (Vardenafil) – US: Patent infringement complaint following a Paragraph IV certification: Bayer Schering Pharma AG et al. v. [read post]
22 Jul 2010, 8:35 am
Ian Bryan, IP Counsel, GE Healthcare Vineet Kohli, Senior Patent Attorney, Merck John Beatty, Patent Procedures Management, European Patent Office Dr Roman Maksymiw, Head of Division, German Patent and Trademark Office, DPMA Lawrence Cullen, Deputy Director, IPO Dr Scott Alban, Head of IP, MedImmune Allen Norris, Vice President, Head Group IP, UCB Pharma SA Peter Thomsen, Manager Global IP Litigation and Global Policy, Novartis International AG … [read post]
14 Jul 2010, 6:47 pm
Abbott Laboratories Ltd v Medinol Ltd (PatLit) US: Analysis shows patent use codes have doubled since August 2003 (FDA Law Blog) US: House slips pay-for-delay provision into Appropriations Bill (Patent Docs) US: Novartis challenges USPTO’s interim procedure for requesting PTA recalculations (Patent Docs) US: Seven actions related to Enzo’s patents for detecting DNA stayed pending Supreme Court review (Patent Docs) US: Review and correction of the patent term adjustment… [read post]
10 May 2010, 9:34 pm
By James DeGiulio -- Celgene and Novartis Reach Settlement with Barr Laboratories in Ritalin ANDA Suit Celgene Corp. and Novartis AG have reached a settlement with Barr Laboratories Inc. over Barr's attempt to market a generic version of the ADHD drug Ritalin. [read post]
22 Apr 2010, 3:51 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
19 Mar 2010, 4:13 am
The FDA is considering expanding the warning labels of the Novartis AG cream Elidel (pimecrolimus) and AStellas Pharma’s Protopic (tacrolimus) used to treat eczema. [read post]
18 Mar 2010, 2:30 am
Astellas Pharma US, Inc. [read post]
10 Mar 2010, 5:22 am
Sun Pharma Global FZE et al. [read post]
10 Mar 2010, 5:22 am
Sun Pharma Global FZE et al. [read post]
10 Feb 2010, 4:47 pm
Aurobindo Pharma Ltd. et al. [read post]
19 Jan 2010, 12:55 pm
On the innovator side, Glaxo and Novartis have settled the most. [read post]
18 Dec 2009, 9:59 am
(patent infringement) 12/10: Seattle Children's Hospital, Novartis AG, Novartis Vaccines and Diagnostics, Inc. and Novartis Pharmaceuticals Corporation v. [read post]
18 Nov 2009, 4:57 am
(Patent Docs) Dovonex (Calcipotriol) – UK: EWHC dismisses Sandoz appeal against Floyd J’s finding that Leo Pharma’s patent was valid (PatLit) Humira (Adalimumab): US: District Court E D Texas upholds record $1.7 billion infringement judgment: Centocor v Abbott (Patent Docs) (EDTexweblog.com) Lexapro (Citalopram) – US: Infosint seeks increased damages award in Citalopram suit (Patent Docs) Myfortic7 (Mycophenolate) – US: Patent infringement suit filed in… [read post]
18 Nov 2009, 4:57 am
(Patent Docs) Dovonex (Calcipotriol) - UK: EWHC dismisses Sandoz appeal against Floyd J's finding that Leo Pharma's patent was valid (PatLit) Humira (Adalimumab): US: District Court E D Texas upholds record $1.7 billion infringement judgment: Centocor v Abbott (Patent Docs) (EDTexweblog.com) Lexapro (Citalopram) - US: Infosint seeks increased damages award in Citalopram suit (Patent Docs) Myfortic7 (Mycophenolate) - US: Patent infringement suit filed in response to Paragraph IV… [read post]
18 Nov 2009, 4:57 am
(Patent Docs) Dovonex (Calcipotriol) - UK: EWHC dismisses Sandoz appeal against Floyd J's finding that Leo Pharma's patent was valid (PatLit) Humira (Adalimumab): US: District Court E D Texas upholds record $1.7 billion infringement judgment: Centocor v Abbott (Patent Docs) (EDTexweblog.com) Lexapro (Citalopram) - US: Infosint seeks increased damages award in Citalopram suit (Patent Docs) Myfortic7 (Mycophenolate) - US: Patent infringement suit filed in response to Paragraph IV… [read post]
8 Nov 2009, 9:28 pm
Novartis AG et al. v. [read post]
30 Aug 2009, 10:00 pm
Bivins (a citizen of Texas) sued Novartis Pharmaceuticals (a Delaware corporation with its principal place of business in New Jersey), Novartis Pharma GmbH (a German corporation), and Novartis AG (a Swiss corporation) in New Jersey state court. [read post]
13 Jul 2009, 6:45 am
(Afro-IP) Spain Trade mark cancellation and damages: a matter of (bad) faith (Class 46) United Kingdom EWHC (Pat): No ruling on hypothetical issue: MMI Research Ltd v Cellxion Ltd (IPKat) EWHC (Pat): EP 258 valid in Netherlands but not UK: Novartis AG and Cibavision AG v Johnson & Johnson Medical Ltd & Ors (PatLit) EWHC: Trial judge says ‘Boileau’ to patent licence; appeal court agrees: Oxonica Energy Ltd v Neuftec… [read post]
25 Jun 2009, 4:29 am
Novartis Pharmaceuticals Corp., 541 F. [read post]
1 May 2009, 9:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
